1. Manuyakorn W, Klangkalya N, Kamchaisatian W, Benjaponpita S, Sasisakulporn C, Jotikasthira W. Efficacy of Nasal Cellulose Powder in the Symptomatic Treatment of Allergic Rhinitis: a Randomized, Double-Blind, Placebo-Controlled Trial. Allergy Asthma Immunol Res. 2017; 9:446–452.
Article
2. Popov TA, Åberg N, Emberlin J, Josling P, Ilyina NI, Nikitin NP, et al. Methyl-cellulose powder for prevention and management of nasal symptoms. Expert Rev Respir Med. 2017; 11:885–892.
Article
3. Diethart B, Emberlin JC, Lewis RA. Hydroxypropylmethylcellulose gel application delays Der p 1 diffusion in vitro. Nat Sci (Irvine). 2010; 2:79–84.
Article
4. Emberlin JC, Lewis RA. A double blind, placebo-controlled cross over trial of cellulose powder by nasal provocation with Der p1 and Der f1. Curr Med Res Opin. 2007; 23:2423–2431.
Article
5. Calderón MA, Linneberg A, Kleine-Tebbe J, De Blay F, Hernandez Fernandez de Rojas D, Virchow JC, et al. Respiratory allergy caused by house dust mites: what do we really know? J Allergy Clin Immunol. 2015; 136:38–48.
Article
6. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010; 126:466–476.
7. Valerieva A, Popov TA, Staevska M, Kralimarkova T, Petkova E, Valerieva E, et al. Effect of micronized cellulose powder on the efficacy of topical oxymetazoline in allergic rhinitis. Allergy Asthma Proc. 2015; 36:e134–e139.
Article